Načítá se...
Zirconium-89-labelled rituximab PET-CT in orbital inflammatory disease
BACKGROUND: Orbital inflammatory diseases are a heterogenic group of conditions that often entail a difficult diagnostic process and many patients are treatment resistant. Inflammatory diseases can be visualized by Zirconium-89-labelled rituximab PET-CT ((89)Zr-rituximab PET/CT). In this study, we d...
Uloženo v:
| Vydáno v: | EJNMMI Res |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer Berlin Heidelberg
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6667535/ https://ncbi.nlm.nih.gov/pubmed/31363937 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13550-019-0530-9 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|